Protein homeostasis in amyotrophic lateral sclerosis: Therapeutic opportunities?

59Citations
Citations of this article
175Readers
Mendeley users who have this article in their library.

Abstract

Protein homeostasis (proteostasis), the correct balance between production and degradation of proteins, is essential for the health and survival of cells. Proteostasis requires an intricate network of protein quality control pathways (the proteostasis network) that work to prevent protein aggregation and maintain proteome health throughout the lifespan of the cell. Collapse of proteostasis has been implicated in the etiology of a number of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), the most common adult onset motor neuron disorder. Here, we review the evidence linking dysfunctional proteostasis to the etiology of ALS and discuss how ALS-associated insults affect the proteostasis network. Finally, we discuss the potential therapeutic benefit of proteostasis network modulation in ALS.

Cite

CITATION STYLE

APA

Webster, C. P., Smith, E. F., Shaw, P. J., & De Vos, K. J. (2017, May 2). Protein homeostasis in amyotrophic lateral sclerosis: Therapeutic opportunities? Frontiers in Molecular Neuroscience. Frontiers Media S.A. https://doi.org/10.3389/fnmol.2017.00123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free